Hu GH, Zuo YX, Zhang XH, Wang Y, et al. Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. Leuk Lymphoma 2026 Jan 7:1-7. doi: 10.1080/10428194.2025.2611117.
PMID: 41498528